Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (NDUFS7), is a core subunit of Complex I of the mitochondrial respiratory chain, vital for electron transfer from NADH to ubiquinone, resulting in generation of a proton gradient used for ATP synthesis. It contains iron-sulfur clusters and is part of the catalytic core involved in electron transfer and proton translocation. Mutations in NDUFS7 cause mitochondrial complex I deficiency, especially Leigh syndrome—a severe neurodegenerative disorder—and other mitochondrial diseases. Dysfunction disrupts complex I assembly, increases oxidative stress, and impairs cellular respiration. NDUFS7 is not a direct therapeutic drug target but is of high clinical relevance in rare genetic and metabolic diseases.
Not applicable—no approved drugs directly targeting this subunit. Experimental modulation relates to complex I inhibition or mitochondrial function alteration, which generally affects electron transfer/proton translocation in NADH:ubiquinone oxidoreductase
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (NDUFS7).